|
Delayed
Hong Kong S.E.
10:57:17 13/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.080 HKD | 0.00% |
|
-2.70% | +35.00% |
| 03/08 | Fusen Pharmaceutical Company Limited Selected in National Centralised Medicines Procurement in China | CI |
| 26/06 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| Market Cap | 69Cr 80Cr 10Cr 8.82Cr 8.26Cr 7.53Cr 14Cr 970.44Cr 14Cr 97Cr 38Cr 485.91Cr 38Cr 37Cr 1.62TCr | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 91Cr 105.68Cr 13Cr 12Cr 11Cr 9.97Cr 19Cr 1.28TCr 19Cr 128.57Cr 50Cr 643.12Cr 51Cr 49Cr 2.14TCr | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -2.70% | ||
| Current month | +6.93% | ||
| 1 month | +3.85% | ||
| 3 months | -4.42% | ||
| 6 months | +16.13% | ||
| Current year | +35.00% |
| 1 week | 1 |  | 1.1 |
| 1 month | 1 | | 1.2 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.31 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/04/24 | Other | Chairman | 6,50,000 | 0.0867% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% | ||
| 18/04/24 | Other | Chairman | 2,40,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.70% | +204.23% | -25.52% | 10Cr | |
| -0.37% | -0.74% | +18.09% | +70.73% | 4.89TCr | |
| +1.18% | +1.85% | +54.92% | +123.82% | 4.04TCr | |
| -2.71% | +5.79% | +18.56% | +82.67% | 1.26TCr | |
| -0.21% | -1.10% | -6.43% | +18.22% | 1.24TCr | |
| -1.35% | -0.76% | +30.40% | +135.91% | 906.84Cr | |
| -0.08% | +7.60% | +24.69% | +40.11% | 752.5Cr | |
| +0.54% | +3.98% | +39.87% | -12.41% | 712.92Cr | |
| +0.66% | +1.32% | +13.33% | +188.33% | 677.55Cr | |
| -0.87% | +2.74% | -25.38% | +28.51% | 583.39Cr | |
| Average | -0.34% | +2.71% | +37.23% | +65.04% | 1.51TCr | |
| Weighted average by Cap. | -0.12% | +2.56% | +26.32% | +83.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33Cr 38Cr 4.83Cr 4.19Cr 3.92Cr 3.58Cr 6.73Cr 461.12Cr 6.83Cr 46Cr 18Cr 230.89Cr 18Cr 18Cr 769.89Cr | 27Cr 32Cr 4.05Cr 3.51Cr 3.29Cr 3Cr 5.64Cr 386.63Cr 5.73Cr 39Cr 15Cr 193.59Cr 15Cr 15Cr 645.53Cr |
| Net income | -19Cr -22Cr -2.8Cr -2.43Cr -2.27Cr -2.07Cr -3.9Cr -267Cr -3.96Cr -27Cr -10Cr -133.69Cr -11Cr -10Cr -445.79Cr | -1.18Cr -1.37Cr -17.47L -15.14L -14.18L -12.94L -24.32L -17Cr -24.7L -1.67Cr -65.22L -8.35Cr -65.61L -64.18L -28Cr |
| Net Debt | 37Cr 43Cr 5.45Cr 4.72Cr 4.42Cr 4.03Cr 7.58Cr 519.41Cr 7.7Cr 52Cr 20Cr 260.07Cr 20Cr 20Cr 867.21Cr | 22Cr 26Cr 3.29Cr 2.85Cr 2.67Cr 2.44Cr 4.58Cr 313.97Cr 4.65Cr 31Cr 12Cr 157.21Cr 12Cr 12Cr 524.21Cr |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | HK$1.080 | 0.00% | 6,000 |
| 12/26/12 | HK$1.080 | +1.89% | 60,000 |
| 11/26/11 | HK$1.060 | 0.00% | 4,000 |
| 10/26/10 | HK$1.060 | -3.64% | 77,000 |
| 07/26/07 | HK$1.100 | -0.90% | 19,000 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
